11 Jul, 2014
The Pharmaceutical Society of Australia’s Self Care program now provides everything a pharmacy needs to run a targeted health promotion.
Chief Executive Officer of the PSA, Dr Lance Emerson, said health promotions were an important part of the changing pharmacy landscape.
“Running a successful health promotion in a pharmacy helps the business make the most of the Community Pharmacy Agreement incentives while improving health outcomes for consumers,” Dr Emerson said. “In recognition of this, PSA’s Self Care program has tailored many of its resources, available only to subscribers in the program, to focus on health promotions. This bank of resources will make it easy for pharmacies to run a health promotion each month – helping them to connect with their local community while improving the health of their customers.”
Dr Emerson said regular health promotions also helped to strengthen the pharmacy’s image as a health destination.
“In addition, it enables the pharmacy to access Government funding through the Pharmacy Practice Incentives (PPI) provided for under the Fifth Community Pharmacy Agreement,” he said.
The 12 health topics currently available are:
- Dose Administration Aids
- Hay fever
- Head lice
- Home Medicine Reviews
- Skin conditions
- Smoking cessation
- Weight management
For each topic, pharmacies can access a one page ‘how to’ document showing the steps in running a health promotion, and a detailed Self Care ACTION planner to plan and run a successful promotion. Subscribers can also order a free marketing kit containing posters and related Fact Cards. In addition, Self Care pharmacies undertaking a health promotion have the facility to incorporate The Health Column into their marketing, access presentations to educate and empower staff, presentations to engage the community, and resources and tools related to the topic.
To find out more about the Self Care Health Promotion Resources visit www.psa.org.au/selfcare/health-promotion-resources
Media contact: Peter Waterman
Public Affairs Director
0419 260 827
This item is listed in the following categories: • Media releases